Support NET Research
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading funder of neuroendocrine tumor (NET) research, having funded more than $30 million in research projects aimed at advancing improved treatments for neuroendocrine tumors. NETRF funds are solely provided by private donations from around the globe. There are many ways to support neuroendocrine tumor (NET) research, such a making a gift, volunteering, or hosting a fundraising event. We hope that the information you find on this page is helpful and will entice you to take the next step in getting involved with NETRF.
Your gift will fund world-class research, empower and educate NET survivors and families and bolster the field of NET research. Learn more about the impact of your gift .
COVID-19 — We Need Your Help
With COVID-19 affecting families around the globe, NETRF needs your support now more than ever. While we all adjust to different routines of school closings, working from home, and cancellation of activities, NET research must continue and not slow down. Giving online is a simple and safe way to make your donation today. Please visit our Give Now page to support NET research. Thank you!
For questions about making your gift, please contact Susan Payson, Chief Development Officer at susan.payson@netrf.org.
The latest in NET News
Clinical Trial of Belzutifan in Pancreatic NETs and Pheo/Para
A phase II clinical trial has opened to investigate the safety and effectiveness of the drug belzutifan for pancreatic neuroendocrine tumors (pNETs) and pheochromocytoma/paraganglioma (PPGL).
Etay Ziv, MD, PhD, Studying NET Progression in NETRF-Funded AACR Research Project
Etay Ziv, MD, PhD, an interventional radiologist at Memorial Sloan Kettering Cancer Center in New York, leads a translational research study, funded by NETRF through the American Association for Cancer Research, that aims to understand the process of how pancreatic NETs progress from low grade to higher, more aggressive grade tumors.
Join the eNET Study!
Doctors at University of California San Francisco (UCSF) are conducting the first-of-its-kind e-NET study to learn about symptoms and quality of life for patients with neuroendocrine cancer. This is your chance to become a citizen scientist and help the researchers learn more about NETs.